|Product name||Recombinant Human BTLA Protein|
|Description||Recombinant Human BTLA Protein is produced by HEK293 expression system. The target protein is expressed with sequence (Lys31-Thr134) of human BTLA (Accession #NP_001078826.1.) fused with an Fc, 6×His tag at the C-terminus.|
|Bio-Activity||Measured by its binding ability in a functional ELISA. Immobilized Recombinant human BTLA at 3μg/mL (100 μL/well) can bind Biotinylated Recombinant human HVEM with a linear range of 18-72 ng/mL.|
|Purity||> 90% by SDS-PAGE.|
|Endotoxin||< 0.1 EU/μg of the protein by LAL method.|
|Formulation||Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation.|
|Expressed Host||HEK293 cells|
|Tag||C-Fc & 6×His|
|Storage||Store the lyophilized protein at -20°C to -80 °C for long term.|
After reconstitution, the protein solution is stable at -20 °C for 3 months, at 2-8 °C for up to 1 week.
|Reconstitution||Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water.|
* For research use only. Not for therapeutic or diagnostic purposes.
Submit your question about RP01052 below and we will get back to you within one business day.
Alternatively, call us at 888.754.5670.